General Information of the Compound
| Compound ID |
CP0430966
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-N-[(4R)-1-acetyl-6-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-3,4-dihydro-2H-quinolin-4-yl]-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanamide;2,2,2-trifluoroacetic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H39F3N4O5
|
||||||||||||||||||
| Molecular Weight |
640.703
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)C(F)(F)F.CC(=O)N1CC[C@@H](NC(=O)[C@@H](N)Cc2c(C)cc(O)cc2C)c2cc(CN3CCc4ccccc4C3)ccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H38N4O3.C2HF3O2/c1-20-14-26(38)15-21(2)27(20)17-29(33)32(39)34-30-11-13-36(22(3)37)31-9-8-23(16-28(30)31)18-35-12-10-24-6-4-5-7-25(24)19-35;3-2(4,5)1(6)7/h4-9,14-16,29-30,38H,10-13,17-19,33H2,1-3H3,(H,34,39);(H,6,7)/t29-,30+;/m0./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZIRIXAUZCMGMRO-XCCPJCIBSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01526, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01549, Mu-type opioid receptor